MedPath

Effect of combined topical solution 2% salicylic acid and erythromycin 4% with erythromycin 4% topical solution in the treatment of mild to moderate acne vulgaris

Not Applicable
Conditions
Mild to modrate acne vulgaris.
Acne vulgaris
Registration Number
IRCT201010094269N3
Lead Sponsor
Deputy of Tabriz University of Medical Sciences and Health Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Exclusion criteria:patients who are using topical or systemic steroids ; patients who are using contraceptive pills (anti-androgen); patients who are used topical or oral anti-acne medications, during the previous month, even include natural and UV light and Herbal and traditional acne treatments; if there are other face dermatosis and other systemic acne accelerator diseases such as Cushing's syndrome, PCO,adrenal hyperplasia, acquired and innate immun deficiency, steroid acne and acneiform lesions and ....; patient's dissatisfaction ;if there are more than 20 inflammatory lesions (papules and pustules) and three nodules or cysts on one side of the face ; patients with acne excoree ;age under 11 y/o andover 30 y/o ;if there is an inflammatory disease,except acne, on the face such as contact dermatitis, allergic or seborrheic dermatitis and...
patients with mild to moderate acne in age range 11-30 years old ; patients who have maximum 20 inflammatory lesions (papules &pustule) on one side of the face and have not more than three nodules or cysts on the same side of the face; lack of other face dermatosis such as contact dermatitis, allergic or seborrheic dermatitis and ...; having patient's satisfaction ; lack of other systemic acne accelerator diseases such as Cushing's syndrome, PCO, adrenal hyperplasia, acquired and innate immun deficiency, steroid acne and acneiform lesions and.... ; patients who are not used of oral or topical anti-acne medications, during the previous month, even include natural and UV light, herbal and traditional acne treatments.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acne severity index. Timepoint: Every15 days. Method of measurement: History, physical examination, counting and statistical evaluation.
Secondary Outcome Measures
NameTimeMethod
Age. Timepoint: Every 15 days. Method of measurement: History.;Gender. Timepoint: Every 15 days. Method of measurement: History.;Comedon. Timepoint: Every 15 days. Method of measurement: Physical examination and counting.;Papule. Timepoint: Every 15 days. Method of measurement: Physical examination and counting.;Pustule. Timepoint: Every 15 days. Method of measurement: Physical examination and counting.;Total numbers of lesions. Timepoint: Every 15 days. Method of measurement: Physical examination and counting.;Patient's satisfaction. Timepoint: Every 15 days. Method of measurement: History.;Side efect of treatment. Timepoint: Every 15 days. Method of measurement: History and physical examination.
© Copyright 2025. All Rights Reserved by MedPath